• Subscribe
    • Sign up for updates about the journal.
  • Sign in
  • Register
Exploration of Medicine
  • About
    • About the Journal
    • Editorial Board
    • Editorial Policies
    • Newsletter
    • Contact Us
  • Articles
    • Current Issue
    • Archives
  • Special Issue
    • All Special Issues
    • Guest Editor Guidelines
  • For Authors
    • Author Instructions
    • Editorial Process
    • Article Processing Charge
    • Submit a Manuscript
  • For Reviewers
    • Peer Review Guidelines
    • Reviewer Acknowledgment
    • To Be a Reviewer
  • Focus
  • Home
  • Exploration of Medicine
  • Newsletter
  • Newsletter

    EM in ASHG 2023

    During November 1-5, our Editor-in-Chief Prof. Lindsay Farrer attended the ASHG 2023 Annual Meeting (American Society of Human Genetics) in Washington, DC, USA, and promoted our journal in this biggest convene of human genetics and genomics research, more than 8,000 attendees around the world this year. With the greatest help of Prof. Farrer, we were so excited to introduce EM and meet the immense community of genetic researchers, clinicians, and educators on-site. See our flyer for ASHG.

    And EM is looking forward to more promotion and collaboration with excellent researchers, associations, and conferences. Join us to do this. You will be fully supported and your effort here will be awarded.

    EM会议传单正(1).jpg

    Nov. 7, 2023

    Winners of Highly Cited Paper Award 2022

    Over the past year, Exploration of Medicine has achieved an increasing impact and larger number of citations. We sincerely thank everyone’s great support! At the beginning of 2023, we are thrilled to announce and recognize the winners of “Highly Cited Paper Award 2022” to show our appreciation to those authors.

    Criteria for Selection and Award:

    ● Original Articles and Reviews published in 2020-2022;

    ● Both regular and special issue submissions are considered;

    ● Citations are counted according to Web of Science (WOS) in 2022;

    ● Prize for the author team: 300-1,000 USD, certificate of “Highly Cited Paper Award”;

    ● Prize for the corresponding Guest Editor(s): 100-300 USD.

    Winning Papers:

    ● PNPLA3 gene and kidney disease

    Alessandro Mantovani, Chiara Zusi

    ● Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin

    Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi, Riccardo Nevola, Luigi Elio Adinolfi, Ferdinando Carlo Sasso

    Special Issue: Exploring NAFLD/NASH

    ● Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease

    Noel C. Salvoza, Pablo J. Giraudi, Claudio Tiribelli, Natalia Rosso

    Special Issue: Exploring NAFLD/NASH

    Congratulations! We believe these articles will be more shining in the future.

    In the following year, we will continue to set “Highly Cited Paper Award” to recognize the related authors. On behalf of the Editorial Board and Editorial Office, we warmly welcome more outstanding researchers to participate in and contribute to the journal. Our thriving journal is always open to you!

    Jan. 18, 2023

    New Editorial Board Members from July to August 2022

    Since July 2022, three talented researchers have joined the Editorial Board of EM. They are (from left to right):

    Prof. Fabio Monzani, PhD (43 of H-Index) from University of Pisa, Italy

    Prof. Tamas Fulop, MD, PhD (66 of H-Index) from University of Sherbrooke, Canada

    Prof. Simona G. Bungau, PhD (33 of H-Index) from University of Oradea, Romania

    Prof. Fabio Monzani and Prof. Tamas Fulop are distinguished experts in the field of geriatrics. Prof. Simona G. Bungau achieved significant work in the fields of pharmacology and public health. It is our great honor to have them in EM, and we hope they will enjoy this new role and have a rewarding experience in EM. For more information about the EM Editorial Board: https://www.explorationpub.com/Journals/em/Editorial_Board.

    Sep. 2, 2022

    New Editorial Board Members from April to June 2022

    Since April 2022, eight talented researchers have joined the Editorial Board of EM. They are:

    Prof. Chao Wang (75 of H-Index) from Soochow University, China;

    Prof. Luis Gabriel Navar (79 of H-Index) from Tulane University School of Medicine, USA;

    Prof. Esma R. Isenovic (29 of H-Index) from University of Belgrade, Serbia;

    Dr. Zeneng Wang (54 of H-Index) from Lerner Research Institute, USA; 

    Prof. Peng Mi (30 of H-Index) from West China Hospital of Sichuan University, China;

    Prof. Guangwen Cao (47 of H-Index) from Naval Medical University, China;

    Prof. Jannis Kountouras (52 of H-Index) from Aristotle University of Thessaloniki, Greece;

    Prof. Jun Ren (80 of H-Index) from Fudan University, China.

    These scholars are all highly accomplished and prominent in their respective research fields. It is our great honor to have them in EM, and we hope they will enjoy their new meaningful role in this promising journal. For more information about the EM Editorial Board: https://www.explorationpub.com/Journals/em/Editorial_Board

    Jun. 15, 2022

    Exploration of Medicine has been COPE Member

    We are so proud to announce that Exploration of Medicine has been COPE (Committee on Publication Ethics) Member. EM has achieved this recognition as a journal committed to the highest standards in publication ethics. Please feel free to check the profile of EM at COPE now: https://publicationethics.org/members/exploration-medicine.

    Apr. 7, 2022

    EM’s application for Scopus has been accepted

    We are thrilled and honored to share this significant breakthrough with all of you: Our application for Scopus has been accepted. Within one month, EM journal will be listed in the Scopus Title list. We thank all our editorial board, authors, reviewers, editorial staff, readers, as you have made tremendous effort and contribution to this rapid milestone and fast development of this journal in just two years since EM launched.

    Mar. 21, 2022

    EM’s application for COPE member approved

    Very cheerfully we cannot wait to share with you the big news: on March 14, EM’s application for COPE (Committee on Publication Ethics) membership was approved! That shows EM's reputation of following the highest standards of publication ethics. And Exploration of Medicine will be in the COPE Member official list in 1-2 weeks.

    Mar. 16, 2022

    Winners of Highly Cited Paper Award 2020–2021

    With great honor and deepest gratitude, Exploration of Medicine has awarded the "Highly Cited Paper Award" in 2020–2021. These inspiring and impactful papers have been enhancing the name and influence of EM since publication. And the authors are heartily recognized for bringing their best contributions.

    Notes for the Award

    – Original research articles and reviews published in 2020 and 2021;

    – Both regular and Special Issue submissions are considered;

    – Citations are counted according to Web of Science (WOS) in 2020 and 2021.

    After careful evaluation based on quality, citations in WOS, and downloads, six articles have been selected, and the author teams will be awarded $1000, $600 and $300 respectively. The authors will also receive a "Highly Cited Paper Award" certificate issued by the journal. In addition, the corresponding Guest Editor will also be awarded $300, $200 and $100 respectively.

    First Prize

    Perspectives of nonalcoholic fatty liver disease research: a personal point of view

    Amedeo Lonardo, Stefano Ballestri

    Special Issue: Exploring NAFLD/NASH

    Second Prize

    Nonalcoholic fatty liver disease and portal hypertension

    Marvin Ryou, Nicholas Stylopoulos, Gyorgy Baffy

    Special Issue: Exploring NAFLD/NASH

    Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin

    Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi, Riccardo Nevola, Luigi Elio Adinolfi, Ferdinando Carlo Sasso

    Special Issue: Exploring NAFLD/NASH

    Third Prize

    Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease

    Noel C. Salvoza, Pablo J. Giraudi, Claudio Tiribelli, Natalia Rosso

    Special Issue: Exploring NAFLD/NASH

    Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions

    Lara Carroll, Leah A. Owen

    Using machine intelligence to uncover Alzheimer's disease progression heterogeneity

    Bessi Qorri, Mike Tsay, Abhishek Agrawal, Rhoda Au, Joseph Geraci

    Special Issue: Digital Biomarkers: The New Frontier for Medicine and Research

    Congratulations to these authors! On behalf of the Editorial Board and Editorial Office, we sincerely appreciate the great support they provided to this rising journal at its early stage. In 2022 we will continue to set the Highly Cited Paper Award to recognize authors who contribute high-quality publications to the journal.

    Jan. 31, 2022

    The publisher Open Exploration in OASPA

    We were honored and pleased to announce our publisher Open Exploration Publishing was recognized as membership of OASPA (Open Access Scholarly Publishing Association). And we believe EM journal will also win a growing name and recognition as our publisher joined this major scholarly organization. https://oaspa.org/member/open-exploration-publishing-inc/

    Nov. 30, 2021

    EM journal indexed in CAS and BASE

    We were honored to be included in CAS and BASE databases. Both are voluminous content providers. Being indexed in CAS and BASE means that EM will receive an increased audience for our articles.

    Find more about CAS and BASE: https://www.cas.org/; https://www.base-search.net/.

    Aug. 6, 2021

    Exploration of Medicine is now indexed in DOAJ!

    We are pleased to announce that Exploration of Medicine is now indexed in the Directory of Open Access Journals (DOAJ), an online directory that indexes and provides access to quality open access, peer-reviewed journals. Check the journal on DOAJ website at https://www.doaj.org/toc/2692-3106. Launched in 2020, this fully Open Access journal continues to grow in scope and influence.

    Jun. 24, 2021

    EM publisher joined Initiative for Open Abstracts

    Open Exploration, publisher of EM, joined the Initiative for Open Abstracts (I4OA) to support the “unrestricted availability of the abstracts of the world's scholarly publications in trusted repositories where they are open and machine-accessible” (from https://i4oa.org/). Read more about it, https://www.explorationpub.com/oep/index/17.

    Dec. 1, 2020

    Dr. George Murphy joined EM as Associate Editor

    With great honor and pleasure, we announced that Dr. George J. Murphy joined our editorial board as the Associate Editor for the section “Regenerative Medicine”. Dr. Murphy is Associate Professor of Medicine in the Division of Hematology and Oncology at Boston University School of Medicine. In addition, he is Co-Director of the Boston University Center for Regenerative Medicine. Meet more talented editorial board of EM here.

    Nov. 30, 2020

    Welcome new Associate Editors

    Join us to welcome our new Associate Editors Dr. Shannon L. Risacher (left, "Radiology, Nuclear Medicine & Imaging" section) and Dr. Lee M. Wetzler (right, "Microbiology, Immunology & Infectious Disease" section). Dr. Risacher is Assistant Professor of Radiology & Imaging Sciences at Indiana University School of Medicine. Dr. Wetzler is Professor of Medicine and Microbiology at Boston University School of Medicine. With their great expertise, we believe they will bring in a particular and wider perspective to the section and journal. Learn more about EM editorial board, https://www.explorationpub.com/Journals/em/Editorial_Board.

    Sep. 9, 2020

    EM listed in "Journals stating that they follow the ICMJE Recommendations"

    Exploration of Medicine is recognized in the list of "Journals stating that they follow the ICMJE Recommendations" (http://www.icmje.org/journals-following-the-icmje-recommendations/). From the first day of EM, we adhere to the ICMJE Recommendations to ensure the rigorousness of review and publication process.

    Aug. 26, 2020
    • Submit a Manuscript
    • Aims and Scope
    • Editorial Board
    • Author Instructions
      • EM in ASHG 2023
      • Winners of Highly Cited Paper Award 2022
      • New Editorial Board Members from July to August 2022
      • New Editorial Board Members from April to June 2022
      • Exploration of Medicine has been COPE Member
      • EM’s application for Scopus has been accepted
      • EM’s application for COPE member approved
      • Winners of Highly Cited Paper Award 2020–2021
      • The publisher Open Exploration in OASPA
      • EM journal indexed in CAS and BASE
      • Exploration of Medicine is now indexed in DOAJ!
      • EM publisher joined Initiative for Open Abstracts
      • Dr. George Murphy joined EM as Associate Editor
      • Welcome new Associate Editors
      • EM listed in "Journals stating that they follow the ICMJE Recommendations"
    • Exploration of Medicine
    • eISSN 2692-3106
    • emjournal@explorationpub.com
    • About the Journal
    • Author Instructions
    • Editorial Board
    • Editorial Policies
    • Editorial Process
    • Follow the Journal
    • JOURNALS
    • Exploration of Medicine
    • Exploration of Targeted Anti-tumor Therapy
    • Exploration of Immunology
    • Exploration of Neuroprotective Therapy
    • Exploration of Digestive Diseases
    • Exploration of Neuroscience
    • Exploration of Musculoskeletal Diseases
    • Exploration of Asthma & Allergy
    • Exploration of Drug Science
    • Exploration of Foods and Foodomics
    • Exploration of BioMat-X
    • Exploration of Digital Health Technologies
    • Exploration of Cardiology
    • Exploration of Endocrine and Metabolic Disease
    • ABOUT
    • Company Information
    • Open Access
    • Editorial Policies
    • Peer Review Policy
    • Contact Us
    • FOLLOW
    • Terms of Service Privacy Cookies
Copyright © 2023 Open Exploration Publishing Inc.